Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 1, 2006British Journal of CancerOpen Access

Neoadjuvant concurrent chemoradiation with weekly paclitaxel and carboplatin for patients with oesophageal cancer: a phase II study

View Full Paper
Ask AI
Bookmark
Share

Authors

EME. van MeertenErasmus MC Cancer InstituteKMKarin MüllerUniversity Medical Center GroningenHTHugo W. TilanusErasmus MC

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Meerten et al. (2006) studied this question.

synapsesocial.com/papers/6a8bca387239707559becfe7https://doi.org/10.1038/sj.bjc.6603134
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Multiinstitutional phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer.1998 · 237 citations
  2. 2Investigation of taxol as a potential radiation sensitizer1993 · 218 citations
  3. 3Randomized Trial of Preoperative Chemoradiation Versus Surgery Alone in Patients With Locoregional Esophageal Carcinoma2001 · 1,277 citations
  4. 4Twice-Weekly Paclitaxel and Weekly Carboplatin With Concurrent Thoracic Radiation Followed by Carboplatin/Paclitaxel Consolidation for Stage III Non–Small-Cell Lung Cancer: A California Cancer Consortium Phase II Trial2001 · 97 citations
  5. 5Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis2004 · 545 citations